Visikol Expands Product Portfolio with New Tissue Slicers
Visikol was originally founded as a products oriented company when it launched its Visikol® HISTO™ portfolio of reagents and [...]
Visikol named to Pharma Tech Outlook’s Top Emerging Pharma Outsourcing Companies of 2021
Pharma Tech Outlook acknowledges Visikol and how the company is leveraging its advanced imaging and 3D cell culture solutions [...]
Using Noise Reduction Methods in ImageJ to Produce High Quality Data
work with us After completing the imaging process for your desired biological model, you may find [...]
Leica Biosystems and Visikol to Host Multiplex Webinar
Visikol CEO Dr. Michael Johnson will be hosting a webinar with Leica Biosystems discussing multiplex imaging and the Leica [...]
Our Multiplex Immunolabeling Approach
Griffin Ferrara2021-02-03T15:56:14-05:00Immunohistochemistry is routinely used to localize and study the distribution of proteins in tissues. Most staining methods are limited [...]
Visikol Launches BitSlide, Cloud-Based Digital Pathology Slide Visualization Platform
Visikol has been a leader in advanced bioimaging through its portfolio of cutting-edge technologies and innovative drug discovery, bioimaging, [...]
Using Immunohistochemistry and Multiplex Slide Labeling for Tumor Research
Accurate prediction and prognosis as well as patient stratification for precision therapy are the most important and difficult issues [...]
Visikol Expands Hampton Facility to Accommodate Service Growth
2020 was a challenging year for all industries and the life sciences field was no exception. Throughout 2020, Visikol [...]
New Year, New Services
Griffin Ferrara2021-01-08T15:14:13-05:00We are excited to finally turn the page on 2020 and get started on 2021 and are looking forward [...]
High Content Screening for Immune Modulators
Cancer immunotherapies that target T cells via the blockage of immune checkpoints are a promising approach for cancer treatment. [...]